Management of metastatic spinal cord compression

Expert Review of Anticancer Therapy

Volumn 10, Issue 5, 2010, Pages 697-708

  Shiue, Kevin ^a   Sahgal, Arjun ^b   Chow, Edward ^b   Lutz, Stephen T ^c   Chang, Eric L ^d   Mayr, Nina A ^e   Wang, Jianz ^e   Cavaliere, Robert ^f   Mendel, Ehud ^g   Lo, Simon S ^e  

^a PURDUE UNIVERSITY   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c Blanchard Valley Regional Cancer Center   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e OHIO STATE UNIVERSITY   (United States)

^f Starling Loving Hall M410 ^*  (United States)

^g Rm 210 Dept Indust Welding S   (United States)

Author keywords

Management; Spinal cord compression

Indexed keywords

DEXAMETHASONE; FLUORODEOXYGLUCOSE F 18;

BACKACHE; CANCER DIAGNOSIS; CANCER GROWTH; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DRUG MEGADOSE; FEASIBILITY STUDY; HISTOLOGY; HUMAN; INTRAOPERATIVE RADIOTHERAPY; LYMPHOMA; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; METASTATIC SPINAL CORD COMPRESSION; MULTIPLE CYCLE TREATMENT; NERVOUS SYSTEM INJURY; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPERATING ROOM PERSONNEL; PARAPLEGIA; PATHOPHYSIOLOGY; PERFORMANCE; PROSPECTIVE STUDY; QUADRIPLEGIA; RADIATION DOSE; REVIEW; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SPINAL CORD COMPRESSION; SPINAL CORD METASTASIS; STENOSIS; STEREOTACTIC BODY RADIATION THERAPY; SURGICAL APPROACH; SYSTEMIC DISEASE; VEIN OCCLUSION; WEAKNESS;

ANIMALS; COMBINED MODALITY THERAPY; DISEASE MANAGEMENT; HUMANS; SPINAL CORD COMPRESSION; SPINAL CORD NEOPLASMS;

EID: 77952492792     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/era.10.47     Document Type: Review

References (118)

1. Barron KD, Hirano A, Araki S, Terry RD. Experiences with metastatic neoplasms involving the spinal cord. Neurology 9 (2), 91-106 (1959).
2. Bach F, Larsen BH, Rohde K et al. Metastatic spinal cord compression. Occurrence, symptoms, clinical presentations and prognosis in 398 patients with spinal cord compression. Acta Neurochir. (Wien) 107 (1-2), 37-43 (1990).
3. Loblaw DA, Laperriere NJ, Mackillop WJ. A population-based study of malignant spinal cord compression in Ontario. Clin. Oncol. (R. Coll. Radiol.) 15 (4), 211-217 (2003).
4. Helweg-Larsen S, Hansen SW, Sorensen PS. Second occurrence of symptomatic metastatic spinal cord compression and findings of multiple spinal epidural metastases. Int. J. Radiat. Oncol. Biol. Phys. 33 (3), 595-598 (1995).
5. Lu C, Gonzalez RG, Jolesz FA, Wen PY, Talcott JA. Suspected spinal cord compression in cancer patients: a multidisciplinary risk assessment. J. Support Oncol. 3 (4), 305-312 (2005).
6. Cole JS, Patchell RA. Metastatic epidural spinal cord compression. Lancet Neurol. 7 (5), 459-466 (2008).
7. Gabriel K, Schiff D. Metastatic spinal cord compression by solid tumors. Semin. Neurol. 24 (4), 375-383 (2004).
8. Quinn JA, DeAngelis LM. Neurologic emergencies in the cancer patient. Semin. Oncol. 27 (3), 311-321 (2000).
9. Spinazze S, Caraceni A, Schrijvers D. Epidural spinal cord compression. Crit. Rev. Oncol. Hematol. 56 (3), 397-406 (2005).
10. Schiff D, O'Neill BP, Suman VJ. Spinal epidural metastasis as the initial manifestation of malignancy: clinical features and diagnostic approach. Neurology 49 (2), 452-456 (1997).
11. Levack P, Graham J, Collie D et al. Don't wait for a sensory level - listen to the symptoms: a prospective audit of the delays in diagnosis of malignant cord compression. Clin. Oncol. (R. Coll. Radiol.) 14 (6), 472-480 (2002).
12. Gilbert RW, Kim JH, Posner JB. Epidural spinal cord compression from metastatic tumor: diagnosis and treatment. Ann. Neurol. 3 (1), 40-51 (1978).
13. Constans JP, de Divitiis E, Donzelli R, Spaziante R, Meder JF, Haye C. Spinal metastases with neurological manifestations. Review of 600 cases. J. Neurosurg. 59 (1), 111-118 (1983).
14. Helweg-Larsen S. Clinical outcome in metastatic spinal cord compression. A prospective study of 153 patients. Acta Neurol. Scand. 94 (4), 269-275 (1996).
15. Schiff D, O'Neill BP, Wang CH, O'Fallon JR. Neuroimaging and treatment implications of patients with multiple epidural spinal metastases. Cancer 83 (8), 1593-1601 (1998).
16. Helweg-Larsen S, Sorensen PS, Kreiner S. Prognostic factors in metastatic spinal cord compression: a prospective study using multivariate analysis of variables influencing survival and gait function in 153 patients. Int. J. Radiat. Oncol. Biol. Phys. 46 (5), 1163-1169 (2000).
17. van der Sande JJ, Boogerd W, Kroger R, Kappelle AC. Recurrent spinal epidural metastases: a prospective study with a complete follow up. J. Neurol. Neurosurg. Psychiatry 66 (5), 623-627 (1999).
18. Chamberlain MC, Kormanik PA. Epidural spinal cord compression: a single institution's retrospective experience. Neuro. Oncol. 1 (2), 120-123 (1999).
19. Loeffler JS, Glicksman AS, Tefft M, Gelch M. Treatment of spinal cord compression: a retrospective analysis. Med. Pediatr. Oncol. 11 (5), 347-351 (1983).
20. Zaidat OO, Ruff RL. Treatment of spinal epidural metastasis improves patient survival and functional state. Neurology 58 (9), 1360-1366 (2002).
21. Prasad D, Schiff D. Malignant spinal-cord compression. Lancet Oncol. 6 (1), 15-24 (2005).
22. Helweg-Larsen S, Sorensen PS. Symptoms and signs in metastatic spinal cord compression: a study of progression from first symptom until diagnosis in 153 patients. Eur. J. Cancer 30A (3), 396-398 (1994).
23. McLinton A, Hutchison C. Malignant spinal cord compression: a retrospective audit of clinical practice at a UK regional cancer centre. Br. J. Cancer 94 (4), 486-491 (2006).
24. Daw HA, Markman M. Epidural spinal cord compression in cancer patients: diagnosis and management. Cleve. Clin. J. Med. 67 (7), 497, 501-494 (2000).
25. Kienstra GE, Terwee CB, Dekker FW et al. Prediction of spinal epidural metastases. Arch. Neurol. 57 (5), 690-695 (2000).
26. Abdi S, Adams CI, Foweraker KL, O'Connor A. Metastatic spinal cord syndromes: imaging appearances and treatment planning. Clin. Radiol. 60 (6), 637-647 (2005).
27. 18F-fluorodeoxyglucose-positron emission tomography. Eur. J. Surg. Oncol. 31 (2), 197-204 (2005).
28. Johnson AJ, Ying J, El Gammal T, Timmerman RD, Kim RY, Littenberg B. Which MR imaging sequences are necessary in determining the need for radiation therapy for cord compression? A prospective study. AJNR Am. J. Neuroradiol. 28 (1), 32-37 (2007).
29. Maranzano E, Latini P, Checcaglini F et al. Radiation therapy in metastatic spinal cord compression. A prospective analysis of 105 consecutive patients. Cancer 67 (5), 1311-1317 (1991).
30. Graham PH, Capp A, Delaney G et al. A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal-cord compression treated by radiotherapy: TROG 01.05 Superdex study. Clin. Oncol. (R. Coll. Radiol.) 18 (1), 70-76 (2006).
31. Sorensen S, Helweg-Larsen S, Mouridsen H, Hansen HH. Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. Eur. J. Cancer 30A (1), 22-27 (1994).
32. Heimdal K, Hirschberg H, Slettebo H, Watne K, Nome O. High incidence of serious side effects of high-dose dexamethasone treatment in patients with epidural spinal cord compression. J. Neurooncol. 12 (2), 141-144 (1992).
33. Vecht CJ, Haaxma-Reiche H, van Putten WL, de Visser M, Vries EP, Twijnstra A. Initial bolus of conventional versus high-dose dexamethasone in metastatic spinal cord compression. Neurology 39 (9), 1255-1257 (1989).
34. Tomita T, Galicich JH, Sundaresan N. Radiation therapy for spinal epidural metastases with complete block. Acta Radiol. Oncol. 22 (2), 135-143 (1983).
35. Findlay GF. Adverse effects of the management of malignant spinal cord compression. J. Neurol. Neurosurg. Psychiatry 47 (8), 761-768 (1984).
36. Portenoy RK, Lipton RB, Foley KM. Back pain in the cancer patient: an algorithm for evaluation and management. Neurology 37 (1), 134-138 (1987).
37. Sherk HH, Nolan JP Jr, Mooar PA. Treatment of tumors of the cervical spine. Clin. Orthop. Relat. Res. (233), 163-167 (1988).
38. Sundaresan N, Scher H, DiGiacinto GV, Yagoda A, Whitmore W, Choi IS. Surgical treatment of spinal cord compression in kidney cancer. J. Clin. Oncol. 4 (12), 1851-1856 (1986).
39. Willson JK, Masaryk TJ. Neurologic emergencies in the cancer patient. Semin. Oncol. 16 (6), 490-503 (1989).
40. Aabo K, Walbom-Jorgensen S. Central nervous system complications by malignant lymphomas: radiation schedule and treatment results. Int. J. Radiat. Oncol. Biol. Phys. 12 (2), 197-202 (1986).
41. Black P. Spinal metastasis: current status and recommended guidelines for management. Neurosurgery 5 (6), 726-746 (1979). (Pubitemid 10155278)
42. Cobb CA 3rd, Leavens ME, Eckles N. Indications for nonoperative treatment of spinal cord compression due to breast cancer. J. Neurosurg 47 (5), 653-658 (1977).
43. Young RF, Post EM, King GA. Treatment of spinal epidural metastases. Randomized prospective comparison of laminectomy and radiotherapy. J. Neurosurg. 53 (6), 741-748 (1980).
44. Maranzano E, Bellavita R, Rossi R et al. Short-course versus split-course radiotherapy in metastatic spinal cord compression: results of a Phase III, randomized, multicenter trial. J. Clin. Oncol. 23 (15), 3358-3365 (2005). Phase III trial comparing different radiotherapy regimens for metastatic spinal cord compression.
45. van der Linden YM, Dijkstra SP, Vonk EJ, Marijnen CA, Leer JW. Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy. Cancer 103 (2), 320-328 (2005).
46. Rades D, Fehlauer F, Stalpers LJ et al. A prospective evaluation of two radiotherapy schedules with 10 versus 20 fractions for the treatment of metastatic spinal cord compression: final results of a multicenter study. Cancer 101 (11), 2687-2692 (2004). Prospective comparison of two radiotherapy schedules with ten versus 20 fractions for the treatment of metastatic spinal cord compression. (Pubitemid 39532303)
47. Rades D, Stalpers LJ, Veninga T et al. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J. Clin. Oncol. 23 (15), 3366-3375 (2005).
48. Maranzano E, Bellavita R, Rossi R. Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. J. Clin. Oncol 23 (32), 8270-8272 (2005).
49. Rades D, Stalpers LJ, Hulshof MC et al. Comparison of 1 x 8 Gy and 10 x 3 Gy for functional outcome in patients with metastatic spinal cord compression. Int. J. Radiat. Oncol. Biol. Phys. 62 (2), 514-518 (2005). (Pubitemid 40704470)
50. Rades D, Stalpers LJ, Hulshof MC, Zschenker O, Alberti W, Koning CC. Effectiveness and toxicity of single-fraction radiotherapy with 1 x 8 Gy for metastatic spinal cord compression. Radiother. Oncol. 75 (1), 70-73 (2005). (Pubitemid 40616797)
51. Falkmer U, Jarhult J, Wersall P, Cavallin-Stahl E. A systematic overview of radiation therapy effects in skeletal metastases. Acta Oncol. 42 (5-6), 620-633 (2003). (Pubitemid 37193849)
52. Maranzano E, Bellavita R, Floridi P et al. Radiation-induced myelopathy in long-term surviving metastatic spinal cord compression patients after hypofractionated radiotherapy: a clinical and magnetic resonance imaging analysis. Radiother. Oncol. 60 (3), 281-288 (2001).
53. Rades D, Karstens JH, Alberti W. Role of radiotherapy in the treatment of motor dysfunction due to metastatic spinal cord compression: comparison of three different fractionation schedules. Int. J. Radiat. Oncol. Biol. Phys. 54 (4), 1160-1164 (2002). Comparison of three different radiotherapy regimens in the treatment of motor dysfunction due to metastatic spinal cord compression.
54. Rades D, Karstens JH, Hoskin PJ et al. Escalation of radiation dose beyond 30 Gy in 10 fractions for metastatic spinal cord compression. Int. J. Radiat. Oncol. Biol. Phys. 67 (2), 525-531 (2007). Examines the impact of escalating the radiation dose beyond 30 Gy in 10 fractions for metastatic spinal cord compression.
55. Rades D, Heidenreich F, Karstens JH. Final results of a prospective study of the prognostic value of the time to develop motor deficits before irradiation in metastatic spinal cord compression. Int. J. Radiat. Oncol. Biol. Phys. 53 (4), 975-979 (2002). Final updates of a study examining the impact of the tempo of development of motor deficits on the eventual chance of ambulation after treatment.
56. Maranzano E, Trippa F, Casale M et al. 8 Gy single-dose radiotherapy is effective in metastatic spinal cord compression: results of a Phase III randomized multicentre Italian trial. Radiother. Oncol. 93 (2), 174-179 (2009). Phase III trial comparing different short-course radiotherapy regimens for metastatic spinal cord compression.
57. Rades D, Lange M, Veninga T et al. Preliminary results of spinal cord compression recurrence evaluation (score-1) study comparing short-course versus long-course radiotherapy for local control of malignant epidural spinal cord compression. Int. J. Radiat. Oncol. Biol. Phys. 73 (1), 228-234 (2009).
58. Rades D, Stalpers LJ, Schulte R et al. Defining the appropriate radiotherapy regimen for metastatic spinal cord compression in non-small cell lung cancer patients. Eur. J. Cancer 42 (8), 1052-1056 (2006).
59. Rades D, Veninga T, Stalpers LJ et al. Prognostic factors predicting functional outcomes, recurrence-free survival, and overall survival after radiotherapy for metastatic spinal cord compression in breast cancer patients. Int. J. Radiat. Oncol. Biol. Phys. 64 (1), 182-188 (2006).
60. Sioutos PJ, Arbit E, Meshulam CF, Galicich JH. Spinal metastases from solid tumors. Analysis of factors affecting survival. Cancer 76 (8), 1453-1459 (1995).
61. Maranzano E, Latini P. Effectiveness of radiation therapy without surgery in metastatic spinal cord compression: final results from a prospective trial. Int. J. Radiat. Oncol. Biol. Phys. 32 (4), 959-967 (1995).
62. Rades D, Walz J, Stalpers LJ et al. Shortcourse radiotherapy (RT) for metastatic spinal cord compression (MSCC) due to renal cell carcinoma: results of a retrospective multi-center study. Eur. Urol 49 (5), 846-852 (2006).
63. Rades D, Veninga T, Stalpers LJ et al. Outcome after radiotherapy alone for metastatic spinal cord compression in patients with oligometastases. J. Clin. Oncol. 25 (1), 50-56 (2007). Examines treatment outcomes after radiotherapy alone for metastatic spinal cord compression in patients with oligometastases. (Pubitemid 350003050)
64. Rades D, Fehlauer F, Veninga T et al. Functional outcome and survival after radiotherapy of metastatic spinal cord compression in patients with cancer of unknown primary. Int. J. Radiat. Oncol. Biol. Phys. 67 (2), 532-537 (2007). (Pubitemid 46108304)
65. Rades D, Hoskin PJ, Karstens JH et al. Radiotherapy of metastatic spinal cord compression in very elderly patients. Int. J. Radiat. Oncol. Biol. Phys. 67 (1), 256-263 (2007).
66. Rades D, Hoskin PJ, Stalpers LJ et al. Short-course radiotherapy is not optimal for spinal cord compression due to myeloma. Int. J. Radiat. Oncol. Biol. Phys. 64 (5), 1452-1457 (2006).
67. Rades D, Walz J, Schild SE, Veninga T, Dunst J. Do bladder cancer patients with metastatic spinal cord compression benefit from radiotherapy alone? Urology 69 (6), 1081-1085 (2007). (Pubitemid 46891582)
68. Rades D, Schild SE, Dunst J. Radiotherapy is effective for metastatic spinal cord compression in patients with epithelial ovarian cancer. Int. J. Gynecol. Cancer 17 (1), 263-265 (2007). (Pubitemid 46214001)
69. Rades D, Rudat V, Veninga T, Stalpers LJ, Hoskin PJ, Schild SE. Prognostic factors for functional outcome and survival after reirradiation for in-field recurrences of metastatic spinal cord compression. Cancer 113 (5), 1090-1096 (2008). Examines the factors affecting functional outcome and survival after reirradiation for in-field recurrences of metastatic spinal cord compression.
70. Rades D, Stalpers LJ, Veninga T, Hoskin PJ. Spinal reirradiation after short-course RT for metastatic spinal cord compression. Int. J. Radiat. Oncol. Biol. Phys. 63 (3), 872-875 (2005). (Pubitemid 41400078)
71. Rades D, Blach M, Bremer M, Wildfang I, Karstens JH, Heidenreich F. Prognostic significance of the time of developing motor deficits before radiation therapy in metastatic spinal cord compression: one-year results of a prospective trial. Int. J. Radiat. Oncol. Biol. Phys. 48 (5), 1403-1408 (2000). A study examining the impact of the tempo of development of motor deficits on the eventual chance of ambulation after treatment.
72. Rades D, Fehlauer F, Schulte R et al. Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression. J. Clin. Oncol. 24 (21), 3388-3393 (2006).
73. Rades D, Veninga T, Stalpers LJ et al. Improved posttreatment functional outcome is associated with better survival in patients irradiated for metastatic spinal cord compression. Int. J. Radiat. Oncol. Biol. Phys. 67 (5), 1506-1509 (2007). (Pubitemid 46467168)
74. Klimo P Jr, Kestle JR, Schmidt MH. Treatment of metastatic spinal epidural disease: a review of the literature. Neurosurg. Focus 15 (5), E1 (2003).
75. Rades D, Rudat V, Veninga T et al. A score predicting posttreatment ambulatory status in patients irradiated for metastatic spinal cord compression. Int. J. Radiat. Oncol. Biol. Phys. 72 (3), 905-908 (2008). Examines the prognostic factors predicting ambulatory status in patients treated with radiotherapy for metastatic spinal cord compression.
76. Findlay GF. The role of vertebral body collapse in the management of malignant spinal cord compression. J. Neurol. Neurosurg. Psychiatry 50 (2), 151-154 (1987).
77. Klimo P Jr, Thompson CJ, Kestle JR, Schmidt MH. A meta-analysis of surgery versus conventional radiotherapy for the treatment of metastatic spinal epidural disease. Neuro. Oncol. 7 (1), 64-76 (2005).
78. Patchell RA, Tibbs PA, Regine WF et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 366 (9486), 643-648 (2005). Phase III trial comparing surgical decompression plus postoperative radiotherapy and radiotherapy alone and the former was proven to be superior.
79. Mannion RJ, Wilby M, Godward S, Lyratzopoulos G, Laing RJ. The surgical management of metastatic spinal disease: prospective assessment and long-term follow-up. Br. J. Neurosurg. 21 (6), 593-598 (2007).
80. Williams BJ, Fox BD, Sciubba DM et al. Surgical management of prostate cancer metastatic to the spine. J. Neurosurg. Spine 10 (5), 414-422 (2009).
81. Wang JC, Boland P, Mitra N et al. Single-stage posterolateral transpedicular approach for resection of epidural metastatic spine tumors involving the vertebral body with circumferential reconstruction: results in 140 patients. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004. J. Neurosurg. Spine 1 (3), 287-298 (2004).
82. Bilsky MH, Boland P, Lis E, Raizer JJ, Healey JH. Single-stage posterolateral transpedicle approach for spondylectomy, epidural decompression, and circumferential fusion of spinal metastases. Spine (Phila. Pa 1976) 25 (17), 2240-2249 (2000).
83. Chen YJ, Chang GC, Chen HT et al. Surgical results of metastatic spinal cord compression secondary to non-small cell lung cancer. Spine (Phila. Pa 1976) 32 (15), E413-E418 (2007).
84. Chen YJ, Hsu HC, Chen KH, Li TC, Lee TS. Transpedicular partial corpectomy without anterior vertebral reconstruction in thoracic spinal metastases. Spine (Phila. Pa 1976) 32 (22), E623-E626 (2007).
85. Fourney DR, Abi-Said D, Rhines LD et al. Simultaneous anterior-posterior approach to the thoracic and lumbar spine for the radical resection of tumors followed by reconstruction and stabilization. J. Neurosurg. 94 (2 Suppl.), 232-244 (2001).
86. Abel R, Keil M, Schlager E, Akbar M. Posterior decompression and stabilization for metastatic compression of the thoracic spinal cord: is this procedure still state of the art? Spinal Cord 46 (9), 595-602 (2008).
87. North RB, LaRocca VR, Schwartz J et al. Surgical management of spinal metastases: analysis of prognostic factors during a 10-year experience. J. Neurosurg. Spine 2 (5), 564-573 (2005).
88. Chaichana KL, Woodworth GF, Sciubba DM et al. Predictors of ambulatory function after decompressive surgery for metastatic epidural spinal cord compression. Neurosurgery 62 (3), 683-692 (2008).
89. Furstenberg CH, Wiedenhofer B, Gerner HJ, Putz C. The effect of early surgical treatment on recovery in patients with metastatic compression of the spinal cord. J. Bone Joint Surg. Br. 91 (2), 240-244 (2009).
90. Chi JH, Gokaslan Z, McCormick P, Tibbs PA, Kryscio RJ, Patchell RA. Selecting treatment for patients with malignant epidural spinal cord compression - does age matter? results from a randomized clinical trial. Spine (Phila. Pa 1976) 34 (5), 431-435 (2009).
91. Sciubba DM, Gokaslan ZL, Suk I et al. Positive and negative prognostic variables for patients undergoing spine surgery for metastatic breast disease. Eur. Spine J. 16 (10), 1659-1667 (2007).
92. Tanaka M, Nakahara S, Ito Y et al. Surgical treatment of metastatic vertebral tumors. Acta Med. Okayama 63 (3), 145-150 (2009).
93. Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T. Surgical strategy for spinal metastases. Spine (Phila. Pa 1976) 26 (3), 298-306 (2001).
94. Bauer H, Tomita K, Kawahara N, Abdel-Wanis ME, Murakami H. Surgical strategy for spinal metastases. Spine (Phila. Pa 1976) 27 (10), 1124-1126 (2002).
95. Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T. Surgical strategy for spinal metastases. Spine (Phila. Pa 1976) 27 (10), 1124-1125 (2002).
96. Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila. Pa 1976) 30 (19), 2186-2191 (2005).
97. Ulmar B, Naumann U, Catalkaya S et al. Prognosis scores of Tokuhashi and Tomita for patients with spinal metastases of renal cancer. Ann. Surg. Oncol. 14 (2), 998-1004 (2007).
98. Putz C, Wiedenhofer B, Gerner HJ, Furstenberg CH. Tokuhashi prognosis score: an important tool in prediction of the neurological outcome in metastatic spinal cord compression: a retrospective clinical study. Spine (Phila. Pa 1976) 33 (24), 2669-2674 (2008).
99. Yamashita T, Aota Y, Kushida K et al. Changes in physical function after palliative surgery for metastatic spinal tumor: association of the revised Tokuhashi score with neurologic recovery. Spine (Phila. Pa 1976) 33 (21), 2341-2346 (2008).
100. Ulmar B, Richter M, Cakir B, Muche R, Puhl W, Huch K. The Tokuhashi score: significant predictive value for the life expectancy of patients with breast cancer with spinal metastases. Spine (Phila. Pa 1976) 30 (19), 2222-2226 (2005).
101. Ulmar B, Huch K, Naumann U et al. Evaluation of the Tokuhashi prognosis score and its modifications in 217 patients with vertebral metastases. Eur. J. Surg. Oncol. 33 (7), 914-919 (2007). (Pubitemid 47279046)
102. Healey JH, Brown HK. Complications of bone metastases: surgical management. Cancer 88 (12 Suppl.), 2940-2951 (2000).
103. Klimo P Jr, Schmidt MH. Surgical management of spinal metastases. Oncologist, 9 (2), 188-196 (2004).
104. Ghogawala Z, Mansfield FL, Borges LF. Spinal radiation before surgical decompression adversely affects outcomes of surgery for symptomatic metastatic spinal cord compression. Spine (Phila. Pa 1976) 26 (7), 818-824 (2001).
105. Lo SS, Fakiris AJ, Teh BS et al. Stereotactic body radiation therapy for oligometastases. Expert Rev. Anticancer Ther. 9 (5), 621-635 (2009).
106. Sahgal A, Larson DA, Chang EL. Stereotactic body radiosurgery for spinal metastases: a critical review. Int. J. Radiat. Oncol. Biol. Phys. 71 (3), 652-665 (2008).
107. Lo SS, Chang EL, Yamada Y, Sloan AE, Suh JH, Mendel E. Stereotactic radiosurgery and radiation therapy for spinal tumors. Expert Rev. Neurother. 7 (1), 85-93 (2007).
108. Lo SS, Fakiris AJ, Chang EL et al. Stereotactic body radiation therapy: a novel treatment modality. Nat. Rev. Clin. Oncol 7 (1), 44-54 (2010).
109. Rock JP, Ryu S, Shukairy MS et al. Postoperative radiosurgery for malignant spinal tumors. Neurosurgery 58 (5), 891-898 (2006).
110. Chang EL, Shiu AS, Mendel E et al. Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J. Neurosurg Spine 7 (2), 151-160 (2007). One of the two prospective trials on the use of stereotactic body radiotherapy for spinal metastases.
111. Gerszten PC, Monaco EA 3rd. Complete percutaneous treatment of vertebral body tumors causing spinal canal compromise using a transpedicular cavitation, cement augmentation, and radiosurgical technique. Neurosurg. Focus 27 (6), E9 (2009).
112. Jin R, Rock J, Jin JY et al. Single fraction spine radiosurgery for myeloma epidural spinal cord compression. J. Exp. Ther. Oncol. 8 (1), 35-41 (2009).
113. Saito T, Kondo T, Hozumi T, Karasawa K, Seichi A, Nakamura K. Results of posterior surgery with intraoperative radiotherapy for spinal metastases. Eur. Spine J. 15 (2), 216-222 (2006).
114. Kondo T, Hozumi T, Goto T, Seichi A, Nakamura K. Intraoperative radiotherapy combined with posterior decompression and stabilization for non-ambulant paralytic patients due to spinal metastasis. Spine (Phila. Pa 1976) 33 (17), 1898-1904 (2008).
115. Ruff RL, Adamson V W, Ruff SS, Wang X. Directed rehabilitation reduces pain and depression while increasing independence and satisfaction with life for patients with paraplegia due to epidural metastatic spinal cord compression. J. Rehabil. Res. Dev. 44 (1), 1-10 (2007).
116. Ruff RL, Ruff SS, Wang X. Persistent benefits of rehabilitation on pain and life quality for nonambulatory patients with spinal epidural metastasis. J. Rehabil. Res. Dev. 44 (2), 271-278 (2007).
117. Tang V, Harvey D, Park Dorsay J, Jiang S, Rathbone MP. Prognostic indicators in metastatic spinal cord compression: using functional independence measure and Tokuhashi scale to optimize rehabilitation planning. Spinal Cord 45 (10), 671-677 (2007).
118. Eva G, Paley J, Miller M, Wee B. Patients' constructions of disability in metastatic spinal cord compression. Palliat. Med. 23 (2), 132-140 (2009).